EFFECT OF MANNOSE-BINDING PROTEIN ON BINDING OF CRYPTOCOCCUS-NEOFORMANS TO HUMAN PHAGOCYTES

被引：30

作者：

LEVITZ, SM ^{[1
]}

TABUNI, A ^{[1
]}

TRESELER, C ^{[1
]}

机构：

[1] BOSTON UNIV, MED CTR HOSP, DEPT MED, BOSTON, MA 02118 USA

来源：

INFECTION AND IMMUNITY | 1993年 / 61卷 / 11期

关键词：

D O I：

10.1128/IAI.61.11.4891-4893.1993

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The capacity of human peripheral blood monocytes, neutrophils, and monocyte-derived macrophages to bind the yeast Cryptococcus neoformans was increased when the phagocytes were cultured on surfaces containing recombinant human mannose-binding protein. In contrast, soluble mannose-binding protein had no effect on cryptococcal binding by phagocytes.

引用

页码：4891 / 4893

页数：3

共 19 条

[1]

BHATTACHARJEE AK, 1984, REV INFECT DIS, V6, P619

[2]

BOBAK DA, 1988, J IMMUNOL, V141, P592

[3]

IKEDA K, 1987, J BIOL CHEM, V262, P7451

[4] THE HUMAN MANNOSE-BINDING PROTEIN FUNCTIONS AS AN OPSONIN [J].

KUHLMAN, M ;

JOINER, K ;

EZEKOWITZ, RAB .

JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (05) :1733-1745

[5]

LEVITZ SM, 1989, J IMMUNOL, V142, P659

[6] DIFFERENTIAL STIMULATION OF MURINE RESIDENT PERITONEAL-CELLS BY SELECTIVELY OPSONIZED ENCAPSULATED AND ACAPSULAR CRYPTOCOCCUS-NEOFORMANS [J].

LEVITZ, SM ;

DIBENEDETTO, DJ .

INFECTION AND IMMUNITY, 1988, 56 (10) :2544-2551

[7] BINDING OF CRYPTOCOCCUS-NEOFORMANS BY HUMAN CULTURED MACROPHAGES - REQUIREMENTS FOR MULTIPLE COMPLEMENT RECEPTORS AND ACTIN [J].

LEVITZ, SM ;

TABUNI, A .

JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (02) :528-535

[8] GROWTH-INHIBITION OF CRYPTOCOCCUS-NEOFORMANS BY CULTURED HUMAN MONOCYTES - ROLE OF THE CAPSULE, OPSONINS, THE CULTURE SURFACE, AND CYTOKINES [J].

LEVITZ, SM ;

FARRELL, TP .

INFECTION AND IMMUNITY, 1990, 58 (05) :1201-1209

[9]

LEVITZ SM, IN PRESS MACROPHAGE, P533

[10] HUMAN LEUKOCYTE-C1Q RECEPTOR BINDS OTHER SOLUBLE-PROTEINS WITH COLLAGEN DOMAINS [J].

MALHOTRA, R ;

THIEL, S ;

REID, KBM ;

SIM, RB .

JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (03) :955-959

← 1 2 →